Immune Response BioPharma, Inc. — Form D/A
Immune Response BioPharma, Inc. of NEW YORK, NY, a company, filed a Form D amendment with the SEC on 2011-08-02. The offering totals $1.0B. Industry: Pharmaceuticals.
Offering
- Filed: 2011-08-02
- Form: D/A
- Accession: 0001524679-11-000003
- Industry: Pharmaceuticals
- Exemptions: 04, 05, 04.1, 06, 04.2, 46, 04.3
- Total offering: $1.0B
- Remaining: $1.0B
- Minimum investment: $10K
- Security types: equity, debt
- Revenue range: No Revenues
- SEC file number: 021-163802
Issuer
- Name: Immune Response BioPharma, Inc.
- CIK: 0001524679
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 244 5TH AVENUE SUITE 1727, NEW YORK, NY, 10001
- Phone: 9172757931
Officers, directors & promoters (1)
| Name | Role | Location |
|---|
| David Robert Buswell | Executive Officer | Atlantic City, NJ |
Other filings by this issuer (3)
More